niflumic acid has been researched along with Bright Disease in 1 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty patients with histologically ascertained blomerulonephritis and proteinuria were treated over an average period of 4 months with 750 mg/die 2-m-trigluoromethylanilino-nicotinic acid (niflumic acid, Actol)." | 3.65 | [Experiences with niflumic acid in inflammatory glomerulopathies]. ( Boeckle, H; Lindenmaier, K; Lüttgen, F; Oechslen, D, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckle, H | 1 |
| Oechslen, D | 1 |
| Lüttgen, F | 1 |
| Lindenmaier, K | 1 |
1 other study available for niflumic acid and Bright Disease
| Article | Year |
|---|---|
[Experiences with niflumic acid in inflammatory glomerulopathies].
Topics: Depression, Chemical; Female; Fibrinogen; Glomerulonephritis; Humans; Male; Nephrotic Syndrome; Nico | 1975 |